N/A
N=176
Evaluation of Ureteral Jets on Cystoscopy
Injury of Ureter
Bottom Line
View on ClinicalTrials.gov: NCT02476448 ↗Enrolled (actual)
176
Serious AEs
2.3%
Results posted
Oct 2019
Primary outcome: Primary: Ureteral Jet Visibility — 22; 35; 27; 41 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Normal saline (Drug); Phenazopyridine (Drug); Dextrose 10% (Drug); Sodium Fluorescein (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Cecilia Calvo
- Primary completion
- Feb 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ureteral Jet Visibility |
22; 35; 27; 41; 17; 9 | — |
| SECONDARY Surgeon Satisfaction |
12; 27; 12; 26; 14; 12 | — |
Summary
This study evaluates 4 different methods to aid surgeons to visualize ureteral jets on cystoscopy.
Eligibility Criteria
Inclusion Criteria
- adult
- undergoing a cystoscopy or as part of their planned procedure
Exclusion Criteria
- Chronic kidney disease
- known prior surgical removal of kidney or ureteral obstruction
- Current ureteral stent placed
- Allergy to any of the interventions
Data sourced from ClinicalTrials.gov (NCT02476448). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.